Showing results (1631-1640 of 1,735) with videos related to

Sort By:
Pageof 174
Frontiers in Pharmacology|December 3, 2019
Transformation of Australian Community Pharmacies Into Good Clinical Practice Compliant Trial Pharmacies for HIV Pre-Exposure ProphylaxisLuxi Lal, Kathleen Ryan, Iris Yi Liu, et al.
Biology Open|July 24, 2019
The Col4a2em1(IMPC)Wtsi mouse line: lessons from the Deciphering the Mechanisms of Developmental Disorders programLukas F Reissig, Anna Nele Herdina, Julia Rose, et al.
British Journal of Anaesthesia|July 9, 2026
Regional anaesthesia and chronic postsurgical pain: a systematic review and network meta-analysisMartin Taylor-Rowan, Iain Mactier, Clareece Nevill, et al.
Frontiers in Immunology|March 22, 2021
Multi-Modal Characterization of Monocytes in Idiopathic Pulmonary Fibrosis Reveals a Primed Type I Interferon Immune PhenotypeEmily Fraser, Laura Denney, Agne Antanaviciute, et al.
Microbiome|May 30, 2026
Remodelling of cystic fibrosis respiratory microbiota in response to extended elexacaftor-tezacaftor-ivacaftor therapyHelen Gavillet, Lauren R Hatfield, Michelle Hardman, et al.
Nature Communications|April 15, 2026
Shared structural mechanisms of alternating access between the secondary peptide transporter SbmA and ABC transportersThijs W Ettema, Satomi Inaba-Inoue, Chancievan Thangaratnarajah, et al.
The American Surgeon|April 25, 2022
Planning for the Next Pandemic: Trauma Injuries Require Pre-COVID-19 Levels of High-Intensity ResourcesAva K Mokhtari, Lydia R Maurer, Yee M Wong, et al.
Journal of Medicinal Chemistry|May 2, 2003
Design, synthesis, and evaluation of benzothiadiazepine hydroxamates as selective tumor necrosis factor-alpha converting enzyme inhibitorsRobert J Cherney, James J-W Duan, Matthew E Voss, et al.
ERJ Open Research|August 28, 2025
Urinary thromboxane and isoprostane levels are elevated in symptom-high T2-biomarker-low severe asthmaMatthew Chad Eastwood, John Busby, Johan Kolmert, et al.
Apoptosis : an International Journal on Programmed Cell Death|June 1, 2014
Capsaicin induces apoptosis in human small cell lung cancer via the TRPV6 receptor and the calpain pathwayJamie K Lau, Kathleen C Brown, Aaron M Dom, et al.
Pageof 174